Cleared Special

VERDICT II, PROFILE II

K031032 · Medtox Diagnostics, Inc. · Toxicology
Jul 2003
Decision
104d
Days
Class 2
Risk

About This 510(k) Submission

K031032 is an FDA 510(k) clearance for the VERDICT II, PROFILE II, a Enzyme Immunoassay, Opiates (Class II — Special Controls, product code DJG), submitted by Medtox Diagnostics, Inc. (Burlington, US). The FDA issued a Cleared decision on July 14, 2003, 104 days after receiving the submission on April 1, 2003. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3650.

Submission Details

510(k) Number K031032 FDA.gov
FDA Decision Cleared SESE
Date Received April 01, 2003
Decision Date July 14, 2003
Days to Decision 104 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code DJG — Enzyme Immunoassay, Opiates
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3650

Similar Devices — DJG Enzyme Immunoassay, Opiates

All 214
Labcorp Fentanyl Urine Visual Test
K252684 · Medtox Diagnostics, Inc. · Jan 2026
Evidence MultiSTAT DOA Urine MultiPlex
K250741 · Randox Laboratories Limited · Jan 2026
LZI Buprenorphine II Enzyme Immunoassay
K253082 · Lin-Zhi International, Inc. · Jan 2026
SEFRIA? Hydrocodone Oral Fluid
K252520 · Immunalysis Corporation · Sep 2025
Healgen? AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen? Immunofluorescence Analyzer (OG-H180)
K251972 · Healgen Scientific, LLC · Aug 2025
LZI Fentanyl III Enzyme Immunoassay
K251634 · Lin-Zhi International, Inc. · Jun 2025